Increased methylation of the whole CpG island or specific CpG sites in the promoter region of the SLC6A4 gene has already been associated with decreased transcription rate [39], lower mRNA concentrations [40], SLEs and recent depressive symptoms [41, 42], family history of depression [43] as well as post-stroke depression [44]. Here, SLC6A4 is linked to depressive disorder.